Company Filing History:
Years Active: 2017
Title: Thomas Erhard: Innovator in Pharmaceutical Chemistry
Introduction
Thomas Erhard is a notable inventor based in Ludwigshafen, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that modulate serotonin receptors. With a total of 2 patents to his name, Erhard's work has the potential to impact the treatment of various conditions and disorders.
Latest Patents
Erhard's latest patents include innovative compounds such as substituted [1,4]diazepino[6,7,1-ij]quinolines, which serve as serotonin 5-HT2C receptor modulators. This invention relates to a compound of formula (I) that is useful for modulating the 5-HT receptor, thereby preventing and/or treating conditions that respond to this modulation. Additionally, he has developed hexahydrodiazepinoquinolines carrying a substituted alkyl radical, which are also aimed at modulating the 5-HT receptor. These compounds are intended for use in pharmaceutical compositions and methods for treating related disorders.
Career Highlights
Throughout his career, Thomas Erhard has worked with prominent companies in the pharmaceutical industry, including AbbVie Deutschland GmbH and Co. KG. His expertise in the field has allowed him to contribute to significant advancements in drug development and therapeutic applications.
Collaborations
Erhard has collaborated with esteemed colleagues such as Gisela Backfisch and Margaretha Henrica Maria Bakker. These partnerships have fostered a collaborative environment that enhances innovation and research in pharmaceutical chemistry.
Conclusion
Thomas Erhard's contributions to the field of pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of various medical conditions.